Rashmi Kumar insider trades: Myriad Genetics (MYGN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rashmi reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | MYGN | ↓ Sell | 15,000 | $4.46 | $67K | Direct | Jun 9, 2026 (1d) |
| Aug 19, 2024 | MYGN | ↓ Sell | 7,500 | $28.01 | $210K | Direct | Aug 20, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MYGN insiders
Open-market trades in the last 12 months
About Rashmi Kumar's insider trades
Rashmi Kumar is a director at Myriad Genetics (MYGN). Since Aug 19, 2024, Rashmi has reported no open-market purchases and 2 sales worth $277K on SEC Form 4. In the last 12 months: 1 sale ($67K).
Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.